A broader view of gene signatures that can be traced to GPER signaling is provided by a recent study by Lappano and Maggiolini analyzing the transcriptomes of ER-negative breast cancer patients from The Cancer Genome Atlas (TCGA) and Molecular Taxonomy of Breast Cancer International Consortium (METABRIC) datasets [49]. The gene discussed is GPER1; the disease is breast cancer.